Type to search

Elio Riboli

Share
Elio Riboli
Director
Imperial College London

Elio Riboli

Professor Elio Riboli’s career started at the Department of Epidemiology of the National Institute of Cancer, Milan (1978-1983). In 1983 he was appointed Medical Officer in Epidemiology at the International Agency for Research on Cancer of the World Health Organisation-United Nations (IARC-WHO) based in Lyon, France.  While at IARC in the mid 1980’s, he engaged a novel area of research focusing on the role of diet, nutrition and endogenous hormones in cancer aetiology. In 1988 this materialised into the initiation of the pilot phase of the European Prospective Investigation into Cancer and Nutrition (EPIC), and its subsequent funding by the “Europe Against Cancer” programme of the European Commission, from 1992 onward. Professor Riboli has since been the European Coordinator and Principal Investigator of EPIC.

In 2006 Professor Riboli moved from IARC to Imperial College where he was initially appointed Professor and Chair in Cancer Epidemiology and Prevention and one year later Head of the Division of Epidemiology, Public Health and Primary Care (DEPHPC). In 2009, he was appointed Director of the newly established Imperial School of Public Health, which ranked among the two top UK academic institutions in Epidemiology, Public Health and Health Services in the 2014 Research Excellence Framework.

Professor Riboli has collaborated for several years with Italian institutions on cancer epidemiology, in particularly with the National Cancer Institute in Milan, the Humanitas Research Center and University, the department of medical sciences of the University of Turin, the cancer prevention center in Florence, the Federico II University and Pascale Institute in Naples and the cancer registry in Ragusa. These collaborations have facilitated the scientific exchange and researchers’ mobility and helped the Italian institutions have a leading role at international level. In 2017, Professor Riboli was appointed Professor of Public Health at Humanitas University.

Posts Featuring Elio Riboli


Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: Illegal string offset 'ID' in /home/customer/www/pharmtechfocus.com/public_html/wp-content/themes/magplus-child/single-people.php on line 101

Warning: addcslashes() expects parameter 1 to be string, array given in /home/customer/www/pharmtechfocus.com/public_html/wp-includes/wp-db.php on line 1539
SomaLogic to Provide 210 Million Protein Measurements to EPIC Researchers to Better Understand and Predict Cancer Development | Pharmtech Focus

SomaLogic to Provide 210 Million Protein Measurements to EPIC Researchers to Better Understand and Predict Cancer Development